Home › Trial NCT05820932
Predicting Cognitive Decline From Androgen Deprivation Therapy
- Trial IDNCT05820932
- StatusTerminated
- PhaseN/A
- Study typeObservational
- SponsorUniversity of California, San Francisco
- Enrollment32
- Start date2023-05-22
- ConditionsProstate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.